Found: 7
Select item for more details and to access through your institution.
Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 3, p. 397, doi. 10.1002/cpdd.1041
- By:
- Publication type:
- Article
Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 11, p. 5028, doi. 10.1210/jc.2010-1041
- By:
- Publication type:
- Article
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4670, doi. 10.1111/bcp.14886
- By:
- Publication type:
- Article
A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignancies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 867, doi. 10.1002/psp4.12799
- By:
- Publication type:
- Article
Carbohydrate Ligands for COVID-19 Spike Proteins.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 330, doi. 10.3390/v14020330
- By:
- Publication type:
- Article